1
|
Callier K, Dantes G, Johnson K, Linden AF. Pediatric ECLS Neurologic Management and Outcomes. Semin Pediatr Surg 2023; 32:151331. [PMID: 37944407 DOI: 10.1016/j.sempedsurg.2023.151331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2023]
Abstract
Neurologic complications associated with extracorporeal life support (ECLS), including seizures, ischemia/infarction, and intracranial hemorrhage significantly increase morbidity and mortality in pediatric and neonatal patients. Prompt recognition of adverse neurologic events may provide a window to intervene with neuroprotective measures. Many neuromonitoring modalities are available with varying benefits and limitations. Several pre-ECLS and ECLS-related factors have been associated with an increased risk for neurologic complications. These may be patient- or circuit-related and include modifiable and non-modifiable factors. ECLS survivors are at risk for long-term neurological sequelae affecting neurodevelopmental outcomes. Possible long-term outcomes range from normal development to severe impairment. Patients should undergo a neurological evaluation prior to discharge, and neurodevelopmental assessments should be included in each patient's structured, multidisciplinary follow-up. Safe pediatric and neonatal ECLS management requires a thorough understanding of neurological complications, neuromonitoring techniques and limitations, considerations to minimize risk, and an awareness of possible long-term ramifications. With a focus on ECLS for respiratory failure, this manuscript provides a review of these topics and summarizes best practice guidelines from international organizations and expert consensus.
Collapse
Affiliation(s)
- Kylie Callier
- Department of Surgery, The University of Chicago Medicine, Chicago, IL, USA
| | - Goeto Dantes
- Department of Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
| | - Kevin Johnson
- Department of Pediatric Surgery, Vanderbilt University School of Medicine, Nashville, TN
| | - Allison F Linden
- Department of Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA
| |
Collapse
|
2
|
Perez NP, Witt EE, Masiakos PT, Layman I, Tonna JE, Ortega G, Qureshi FG. Associations of cephalad drainage in neonatal veno-venous ECMO - A mixed-effects, propensity score adjusted retrospective analysis of 20 years of ELSO data. J Pediatr Surg 2023; 58:432-439. [PMID: 36328821 DOI: 10.1016/j.jpedsurg.2022.09.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/17/2022] [Revised: 09/19/2022] [Accepted: 09/28/2022] [Indexed: 11/11/2022]
Abstract
BACKGROUND Neurologic complications can occur during neonatal Veno-Venous (VV) ECMO. The addition of a cephalad drainage cannula (i.e., VVDL+V) to dual lumen cannulation (i.e., VVDL) has been advocated to reduce such complications, but previous studies have presented mixed results. METHODS Data from the ECMO Registry of the Extracorporeal Life Support Organization was used to extract all neonates (≤28 days old) who underwent VV ECMO for respiratory support between 2000 and 2019. Primary outcomes were mortality, conversion to Veno-Arterial (VA) ECMO, pump flows, and complications. A mixed-effects, propensity score adjusted analysis was performed. RESULTS 4,275 neonates underwent VV ECMO, 581 (13.6%) via VVDL+V cannulation, and 3,694 (86.4%) via VVDL. On unadjusted analyses, VVDL+V patients had higher rates of mortality (25.5% vs 19.0%, p<0.001), conversion to VA ECMO (14.5% vs 4.1%, p<0.001), and higher pump flows at 4 h from ECMO initiation (112.7 vs 105.5 mL/Kg/min, p<0.001), but lower at 24 h (100.3 vs 104.0 mL/Kg/min, p = 0.004), and a higher proportion of them experienced hemorrhagic (29.3% vs 18.3%, p<0.001), cardiovascular (60.8% vs 45.8%, p<0.001), and mechanical (42.5% vs 32.6%, p<0.001) complications compared to VVDL patients. After adjusting for propensity scores and the multi-level nature of ELSO data, there were no differences in neurologic outcomes, pump flows, or mortality. Rather, VVDL+V cannulation was associated with higher rates of conversion to VA ECMO (adjusted odds ratio [AOR] 43.3, 95% CI 24.3 - 77.4, p<0.001), and increased mechanical (AOR 2.2, 95% CI 1.6 - 3.0, p<0.001) and hemorrhagic (AOR 2.0, 95% CI 1.4 - 3.0, p<0.001) complications. CONCLUSIONS In this analysis, VVDL+V cannulation was not associated with any improvement in neurologic outcomes, pump flows, or mortality, but was rather associated with higher rates of conversion to Veno-Arterial ECMO, mechanical, and hemorrhagic complications.
Collapse
Affiliation(s)
- Numa P Perez
- Department of Surgery, Division of Pediatric Surgery, Massachusetts General Hospital, Boston, MA, United States of America; Healthcare Transformation Lab, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
| | - Emily E Witt
- Department of Surgery, Division of Pediatric Surgery, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States of America
| | - Peter T Masiakos
- Department of Surgery, Division of Pediatric Surgery, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America
| | - Ilan Layman
- Department of Surgery, Alpert Medical School of Brown University, Providence, RI, United States of America
| | - Joseph E Tonna
- Extracorporeal Life Support Organization, Ann Arbor, MI, United States of America; Department of Cardiothoracic Surgery, Department of Emergency Medicine, University Hospital, University of Utah, Salt Lake City, UT, United States of America
| | - Gezzer Ortega
- Harvard Medical School, Boston, MA, United States of America; Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States of America
| | - Faisal G Qureshi
- Department of Surgery, Division of Pediatric Surgery University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Children's Medical Center Dallas, Dallas, TX, United States of America
| |
Collapse
|
3
|
Rose AT, Keene S. Changing populations being treated with ECMO in the neonatal period - who are the others? Semin Fetal Neonatal Med 2022; 27:101402. [PMID: 36414493 DOI: 10.1016/j.siny.2022.101402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Extracorporeal life support via extracorporeal membrane oxygenation (ECMO) has served the sickest of neonates for almost 50 years. Naturally, the characteristics of neonates receiving ECMO have changed. Advances in care have averted the need for ECMO for some, while complex cases with uncertain outcomes, previously not eligible for ECMO, are now considered. Characterizing the disease states and outcomes for neonates on ECMO is challenging as many infants do not fall into classic categories, i.e. meconium aspiration syndrome (MAS), respiratory distress syndrome (RDS), or congenital diaphragmatic hernia (CDH). Since 2017, over one third of neonatal respiratory ECMO runs reported to the Extracorporeal Life Support Organization Registry are grouped as Other, a catch-all that encompasses those with a diagnosis not included in the classic categories. This review summarizes the historical neonatal ECMO population, reviews advances in therapy and technology impacting neonatal care, and addresses the unknowns in the ever-growing category of Other.
Collapse
Affiliation(s)
- Allison T Rose
- Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, NE, Atlanta, GA, 30322, USA.
| | - Sarah Keene
- Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Drive, NE, Atlanta, GA, 30322, USA.
| |
Collapse
|
4
|
Rose AT, Davis J, Williams HO, Clifton M, Paden M, Keene SD. Utility of cephalic drains in infants receiving extracorporeal membrane oxygenation. Perfusion 2022; 38:747-754. [PMID: 35343293 DOI: 10.1177/02676591221080506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
INTRODUCTION The addition of cephalic drains (CDs) in extracorporeal membrane oxygenation (ECMO) to augment venous drainage may offer benefit, though their use is varied. Our objective was to describe our institution's experience with CDs including flow rates and patency. We also compared complication rates between patients with and without a CD. METHODS This retrospective cohort study included infants <12 months of age cannulated for ECMO between January 1, 2010 and September 30, 2019 at a single institution. Flow data were obtained for those with a CD. Demographic and complication rates were obtained for all. RESULTS Of 264 patients in the final cohort, 220 (83%) had a CD of which 93.2% remained patent to decannulation. CDs typically provided 30% or more of ECMO flow throughout the ECMO run. The median time to CD clot was 139 h (range 48-635 h). Patients with a clotted CD had longer ECMO runs than those whose CD remained patent (median 382 h [IQR 217-538] vs 139 h [IQR 91-246], p < 0.001). Survival to discharge was lower for those with clotted versus patent CD (14% vs 70%, p < 0.001). Mechanical complications were more common in patients with CD (p = 0.005). Seizures were more common in those without a CD (p = 0.021). CONCLUSIONS In this cohort, the majority of CDs placed remained patent at decannulation and provided substantial additional venous drainage. Mechanical problems were common in patients with CDs, but without clinical sequelae. Further study is warranted to elucidate CD impact on short- and long-term outcomes.
Collapse
Affiliation(s)
- Allison T Rose
- Division of Neonatology, Department of Pediatrics, 12239Emory University School of Medicine, Atlanta, GA, USA.,138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA
| | - Joel Davis
- 138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA
| | - Helen O Williams
- Division of Neonatology, Department of Pediatrics, 12239Emory University School of Medicine, Atlanta, GA, USA.,138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA
| | - Matthew Clifton
- 138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA.,Department of Surgery, 12239Emory University School of Medicine, Atlanta, GA, USA
| | - Matthew Paden
- 138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA.,Division of Critical Care, Department of Pediatrics, 12239Emory University School of Medicine, Atlanta, GA, USA
| | - Sarah D Keene
- Division of Neonatology, Department of Pediatrics, 12239Emory University School of Medicine, Atlanta, GA, USA.,138610Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USA
| |
Collapse
|
5
|
Melbourne L, Wien MA, Whitehead MT, Ridore M, Wang Y, Short BL, Bulas D, Massaro AN. Risk Factors for Brain Injury in Newborns Treated with Extracorporeal Membrane Oxygenation. Am J Perinatol 2021; 38:1557-1564. [PMID: 32674203 DOI: 10.1055/s-0040-1714208] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
OBJECTIVE This study aimed to assess the association of clinical risk factors with severity of magnetic resonance imaging (MRI) brain injury in neonatal extracorporeal membrane oxygenation (ECMO) patients. STUDY DESIGN This is a single-center retrospective study conducted at an outborn level IV neonatal intensive care unit in a free-standing academic children's hospital. Clinical and MRI data from neonates treated with ECMO between 2005 and 2015 were reviewed. MRI injury was graded by two radiologists according to a modified scoring system that assesses parenchymal injury, extra-axial hemorrhage, and cerebrospinal fluid spaces. MRI severity was classified as none (score = 0), mild/moderate (score = 1-13.5), and severe (score ≥ 14). The relationship between selected risk factors and MRI severity was assessed by Chi-square, analysis of variance, and Kruskal-Wallis tests where appropriate. Combinative predictive ability of significant risk factors was assessed by logistic regression analyses. RESULTS MRI data were assessed in 81 neonates treated with ECMO. Veno-arterial (VA) patients had more severe injury compared with veno-venous patients. There was a trend toward less severe injury over time. After controlling for covariates, duration of ECMO remained significantly associated with brain injury, and the risk for severe injury was significantly increased in patients on ECMO beyond 210 hours. CONCLUSION Risk for brain injury is increased with VA ECMO and with longer duration of ECMO. Improvements in care may be leading to decreasing incidence of brain injury in neonatal ECMO patients. KEY POINTS · Veno-arterial ECMO is associated with more brain injury by MRI compared with veno-venous ECMO.. · Longer duration of ECMO is significantly associated with severe brain injury by MRI.. · Risk for neurologic injury may be decreasing over time with advances in neonatal ECMO..
Collapse
Affiliation(s)
- Launice Melbourne
- Division of Neonatology, Children's National Hospital, Washington, District of Columbia.,Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia
| | - Michael A Wien
- Division of Diagnostic Imaging and Radiology, Children's National Hospital, Washington, District of Columbia
| | - Matthew T Whitehead
- Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia.,Division of Diagnostic Imaging and Radiology, Children's National Hospital, Washington, District of Columbia
| | - Michelande Ridore
- Division of Neonatology, Children's National Hospital, Washington, District of Columbia
| | - Yunfei Wang
- Division of Biostatistics and Study Methodology, Children's National Research Institute, Washington, District of Columbia
| | - Billie L Short
- Division of Neonatology, Children's National Hospital, Washington, District of Columbia.,Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia
| | - Dorothy Bulas
- Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia.,Division of Diagnostic Imaging and Radiology, Children's National Hospital, Washington, District of Columbia
| | - An N Massaro
- Division of Neonatology, Children's National Hospital, Washington, District of Columbia.,Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia
| |
Collapse
|
6
|
Agarwal P, Natarajan G, Sullivan K, Rao R, Rintoul N, Zaniletti I, Keene S, Mietzsch U, Massaro AN, Billimoria Z, Dirnberger D, Hamrick S, Seabrook RB, Weems MF, Cleary JP, Gray BW, DiGeronimo R. Venovenous versus venoarterial extracorporeal membrane oxygenation among infants with hypoxic-ischemic encephalopathy: is there a difference in outcome? J Perinatol 2021; 41:1916-1923. [PMID: 34012056 DOI: 10.1038/s41372-021-01089-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 04/01/2021] [Accepted: 04/29/2021] [Indexed: 01/31/2023]
Abstract
OBJECTIVE Our hypothesis was that among infants with hypoxic-ischemic encephalopathy (HIE), venoarterial (VA), compared to venovenous (VV), extracorporeal membrane oxygenation (ECMO) is associated with an increased risk of mortality or intracranial hemorrhage (ICH). DESIGN/METHODS Retrospective cohort analysis of infants in the Children's Hospitals Neonatal Database from 2010 to 2016 with moderate or severe HIE, gestational age ≥36 weeks, and ECMO initiation <7 days of age. The primary outcome was mortality or ICH. RESULTS Severe HIE was more common in the VA ECMO group (n = 57), compared to the VV ECMO group (n = 53) (47.4% vs. 26.4%, P = 0.02). VA ECMO was associated with a significantly higher risk of death or ICH [57.9% vs. 34.0%, aOR 2.39 (1.08-5.28)] and mortality [31.6% vs. 11.3%, aOR 3.06 (1.08-8.68)], after adjusting for HIE severity. CONCLUSIONS In HIE, VA ECMO was associated with a higher incidence of mortality or ICH. VV ECMO may be beneficial in this population.
Collapse
Affiliation(s)
- Prashant Agarwal
- Department of Pediatrics, Children's Hospital of Michigan/Central Michigan University, Detroit, MI, USA.
| | - Girija Natarajan
- Department of Pediatrics, Children's Hospital of Michigan/Central Michigan University, Detroit, MI, USA
| | - Kevin Sullivan
- Department of Pediatrics, AI duPont Hospital for Children/Thomas Jefferson University, Wilmington, DE, USA
| | - Rakesh Rao
- Department of Pediatrics, Washington University in St. Louis, St Louis, MO, USA
| | - Natalie Rintoul
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | | | - Sarah Keene
- Department of Pediatrics, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, USA
| | - Ulrike Mietzsch
- Department of Pediatrics, Seattle Children's Hospital/University of Washington, Seattle, WA, USA
| | - An N Massaro
- Department of Pediatrics, The George Washington University School of Medicine and Children's National Hospital, Washington DC, DC, USA
| | - Zeenia Billimoria
- Department of Pediatrics, Seattle Children's Hospital/University of Washington, Seattle, WA, USA
| | - Daniel Dirnberger
- Department of Pediatrics, AI duPont Hospital for Children, Wilmington, DE, USA
| | - Shannon Hamrick
- Department of Pediatrics, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, USA
| | - Ruth B Seabrook
- Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA
| | - Mark F Weems
- Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN, USA
| | - John P Cleary
- Department of Pediatrics, Children's Hospital of Orange County, Orange, CA, USA
| | - Brian W Gray
- Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Robert DiGeronimo
- Department of Pediatrics, Seattle Children's Hospital/University of Washington, Seattle, WA, USA
| | | |
Collapse
|
7
|
Keene SD, Patel RM, Stansfield BK, Davis J, Josephson CD, Winkler AM. Blood product transfusion and mortality in neonatal extracorporeal membrane oxygenation. Transfusion 2019; 60:262-268. [PMID: 31837026 DOI: 10.1111/trf.15626] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2019] [Revised: 11/21/2019] [Accepted: 11/21/2019] [Indexed: 01/28/2023]
Abstract
BACKGROUND Neonates receiving extracorporeal membrane oxygenation (ECMO) support are transfused large volumes of red blood cells (RBCs) and platelets (PLTs). Transfusions are often administered in response to specific, but largely unstudied thresholds. The aim of this study is to examine the relationship between RBC and PLT transfusion rates and mortality in neonates receiving ECMO support. STUDY DESIGN AND METHODS We retrospectively examined outcomes of neonates receiving ECMO support in the neonatal intensive care unit (NICU) for respiratory failure between 2010 and 2016 at a single quaternary-referral NICU. We examined the association between RBC and PLT transfusion rate (mL per kg per day) and in-hospital mortality, adjusting for confounding by using a validated composite baseline risk score (Neo-RESCUERS). RESULTS Among the 110 neonates receiving ECMO support, in-hospital mortality was 28%. The median RBC transfusion rate (mL/kg/d) after cannulation was greater among non-survivors, compared to survivors: 12.4 (IQR 9.3-16.2) versus 7.3 (IQR 5.1-10.3), p < 0.001. Similarly, PLT transfusion rate was greater among non-survivors: 22.9 (9.3-16.2) versus 12.1 (8.4-20.1), p = 0.02. After adjusting for baseline mortality risk, both RBC transfusion (adjusted relative risk per 5 mL/kg/d increase: 1.33; 95% CI 1.05-1.69, p = 0.02) and PLT transfusion (adjusted relative risk per 5 mL/kg/d increase: 1.12; 95% CI 1.02-1.23, p = 0.02) were both associated with in-hospital mortality. CONCLUSIONS RBC and PLT transfusion rates are associated with in-hospital mortality among neonates receiving ECMO. These data provide a basis for future studies evaluating more restrictive transfusion practices for neonates receiving ECMO support.
Collapse
Affiliation(s)
- Sarah D Keene
- Children's Healthcare of Atlanta, Atlanta, Georgia.,Emory University School of Medicine, Atlanta, Georgia.,Emory + Children's Pediatric Institute, Atlanta, Georgia
| | - Ravi Mangal Patel
- Children's Healthcare of Atlanta, Atlanta, Georgia.,Emory University School of Medicine, Atlanta, Georgia.,Emory + Children's Pediatric Institute, Atlanta, Georgia
| | | | - Joel Davis
- Children's Healthcare of Atlanta, Atlanta, Georgia
| | - Cassandra D Josephson
- Children's Healthcare of Atlanta, Atlanta, Georgia.,Emory University School of Medicine, Atlanta, Georgia
| | - Anne M Winkler
- Emory University School of Medicine, Atlanta, Georgia.,Instrumentation Laboratory, Bedford, Massachusetts
| |
Collapse
|
8
|
Sewell EK, Piazza AJ, Davis J, Heard ML, Figueroa J, Keene SD. Inotrope Needs in Neonates Requiring Extracorporeal Membrane Oxygenation for Respiratory Failure. J Pediatr 2019; 214:128-133. [PMID: 31443896 DOI: 10.1016/j.jpeds.2019.07.029] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Revised: 06/03/2019] [Accepted: 07/11/2019] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To evaluate how inotropic requirements in neonates with respiratory failure are affected by extracorporeal membrane oxygenation (ECMO) mode and whether high requirements predict mortality. STUDY DESIGN This retrospective chart review included all neonates undergoing ECMO for primary respiratory failure from 2010 to 2016 at a single institution. The vasoactive inotropy score (VIS) was calculated as described in the literature. Data were analyzed with descriptive statistics and univariate analyses. RESULTS Of the 110 identified neonates, 96 underwent venovenous (VV) (87%), 11 (10%) venoarterial, and 3 (3%) converted from VV to venoarterial. The median precannulation VIS score was 33.02 for patients who underwent VV compared with 28.93 for venoarterial (P = .25) and 15 for infants converted. VIS decreased dramatically by 4 hours of ECMO in both groups. The VIS before cannulation was similar in survivors and nonsurvivors, but was significantly higher in nonsurvivors after 24 hours of ECMO (median VIS, 12 [IQR, 8-25] vs 8 [IQR, 3.0-14.5]; P = .035) and at decannulation (10 [IQR, 7-19] vs 3 [IQR, 0-7]; P < .001). CONCLUSIONS Neonates with respiratory failure can be successfully managed on VV ECMO even with considerable vasoactive requirements. Vasoactive requirement after 24 hours of ECMO was predictive of mortality.
Collapse
Affiliation(s)
- Elizabeth K Sewell
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Division of Neonatology Children's Healthcare of Atlanta, Atlanta, GA; Emory + Children's Pediatric Institute, Atlanta, GA
| | - Anthony J Piazza
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Division of Neonatology Children's Healthcare of Atlanta, Atlanta, GA; Emory + Children's Pediatric Institute, Atlanta, GA
| | - Joel Davis
- ECMO and Advanced Technologies, Children's Healthcare of Atlanta, Atlanta, GA
| | - Micheal L Heard
- ECMO and Advanced Technologies, Children's Healthcare of Atlanta, Atlanta, GA
| | - Janet Figueroa
- Biostatistic Core, Emory + Children's Research Alliance, Atlanta, GA
| | - Sarah D Keene
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Division of Neonatology Children's Healthcare of Atlanta, Atlanta, GA; Emory + Children's Pediatric Institute, Atlanta, GA
| |
Collapse
|
9
|
Abstract
Extracorporeal membrane oxygenation (ECMO), a life-saving therapy for respiratory and cardiac failure, was first used in neonates in the 1970s. The indications and criteria for ECMO have changed over the years, but it continues to be an important option for those who have failed other medical therapies. Since the Extracorporeal Life Support Organization (ELSO) Registry was established in 1989, more than 29,900 neonates have been placed on ECMO for respiratory failure, with 84% surviving their ECMO course, and 73% surviving to discharge or transfer. In this chapter, we will review the basics of ECMO, patient characteristics and criteria, patient management, ECMO complications, special uses of neonatal ECMO, and patient outcomes.
Collapse
Affiliation(s)
- Kathryn Fletcher
- Department of Pediatrics, Division of Neonatology, LAC + USC Medical Center, Keck School of Medicine of University of Southern California, Los Angeles, CA; Division of Neonatology, Fetal and Neonatal Institute, Children's Hospital Los Angeles, Los Angeles, CA; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA
| | - Rachel Chapman
- Department of Pediatrics, Division of Neonatology, LAC + USC Medical Center, Keck School of Medicine of University of Southern California, Los Angeles, CA; Division of Neonatology, Fetal and Neonatal Institute, Children's Hospital Los Angeles, Los Angeles, CA; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA.
| | - Sarah Keene
- Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, GA; Children's Healthcare of Atlanta, Atlanta, GA
| |
Collapse
|
10
|
Sigalet DL. Neonatal venovenous ECMO: Should we use it more? Qatar Med J 2017. [PMCID: PMC5474600 DOI: 10.5339/qmj.2017.swacelso.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|